Home › Hereditary Sensory and Autonomic Neuropathies › Oregon
Pag-aaral pangklinika para sa Hereditary Sensory and Autonomic Neuropathies sa Oregon
6 pag-aaral para sa Hereditary Sensory and Autonomic Neuropathies ang naghahanap ng mga kalahok sa mga site sa Oregon.
Mga Lungsod sa Oregon
Opisyal na teksto ng pag-aaral (English)
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Bend Memorial Clinic, Bend
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Oregon Health & Science University, Portland
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Providence Cancer Institute Franz Clinic, Portland
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
- Oncology Associates of Oregon, Springfield
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07558733Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Oncology Associates of Oregon, P.C., Eugene
- Northwest Cancer Specialists, P.C., Portland
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Dis 24, 2025 · NCT06463028Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.